Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Current funding rates on major CEX and DEX platforms indicate that the market remains overall bearish

Current funding rates on major CEX and DEX platforms indicate that the market remains overall bearish

BlockBeatsBlockBeats2026/04/21 16:41
Show original

BlockBeats News, April 22, according to Coinglass data, as Bitcoin slightly rises and remains volatile, current mainstream CEX and DEX funding rates indicate the market is still broadly bearish, with specific funding rates shown in the attached image.


BlockBeats note: The funding rate is a fee set by cryptocurrency trading platforms to keep contract prices aligned with the underlying asset price, typically applied to perpetual contracts. It is a mechanism for capital exchange between long and short traders; trading platforms do not charge this fee but use it to adjust the cost or profit of holding contracts, ensuring contract prices remain close to the underlying asset price.


When the funding rate is 0.01%, it indicates the benchmark rate. When the funding rate exceeds 0.01%, it means the market is generally bullish. When the funding rate is below 0.005%, it means the market is generally bearish.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.

Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.

智通财经•2026/10/26 04:20
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.

Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks

Goldman Sachs stated that the Japanese yen has become a better tool for hedging against AI shocks, with policy shifts reducing the risk of depreciation. The bank recommends shorting USD/JPY and EUR/JPY.

智通财经•2026/10/26 03:41
Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks